

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.76582478 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 9.63319441 |
| 3 | complement activation, alternative pathway (GO:0006957) | 9.17300614 |
| 4 | drug catabolic process (GO:0042737) | 9.15411597 |
| 5 | regulation of protein activation cascade (GO:2000257) | 8.32602319 |
| 6 | regulation of complement activation (GO:0030449) | 7.99810766 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.95310378 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 7.95310378 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.69848880 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 7.69848880 |
| 11 | regulation of fibrinolysis (GO:0051917) | 7.47256158 |
| 12 | ethanol oxidation (GO:0006069) | 7.32689398 |
| 13 | glyoxylate metabolic process (GO:0046487) | 7.04528609 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 7.00073485 |
| 15 | fibrinolysis (GO:0042730) | 6.61712465 |
| 16 | urea metabolic process (GO:0019627) | 6.46510348 |
| 17 | drug metabolic process (GO:0017144) | 6.39887554 |
| 18 | oxidative demethylation (GO:0070989) | 6.18698790 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.09407307 |
| 20 | protein carboxylation (GO:0018214) | 6.09407307 |
| 21 | ethanol metabolic process (GO:0006067) | 5.92044632 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 5.81960424 |
| 23 | imidazole-containing compound metabolic process (GO:0052803) | 5.81522995 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 5.76026885 |
| 25 | bile acid biosynthetic process (GO:0006699) | 5.55785768 |
| 26 | negative regulation of protein activation cascade (GO:2000258) | 5.50950482 |
| 27 | cellular glucuronidation (GO:0052695) | 5.48046954 |
| 28 | protein activation cascade (GO:0072376) | 5.47064339 |
| 29 | complement activation (GO:0006956) | 5.46643715 |
| 30 | urea cycle (GO:0000050) | 5.45604043 |
| 31 | opsonization (GO:0008228) | 5.40584153 |
| 32 | complement activation, classical pathway (GO:0006958) | 5.40242735 |
| 33 | blood coagulation, intrinsic pathway (GO:0007597) | 5.38285103 |
| 34 | uronic acid metabolic process (GO:0006063) | 5.14166616 |
| 35 | glucuronate metabolic process (GO:0019585) | 5.14166616 |
| 36 | phenylpropanoid metabolic process (GO:0009698) | 4.94463915 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.93773979 |
| 38 | regulation of humoral immune response (GO:0002920) | 4.87282756 |
| 39 | regulation of plasminogen activation (GO:0010755) | 4.85339365 |
| 40 | acute-phase response (GO:0006953) | 4.85204973 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.81203911 |
| 42 | * bile acid metabolic process (GO:0008206) | 4.71458374 |
| 43 | negative regulation of complement activation (GO:0045916) | 4.68013020 |
| 44 | cytolysis (GO:0019835) | 4.66021386 |
| 45 | glycine metabolic process (GO:0006544) | 4.63457205 |
| 46 | negative regulation of blood coagulation (GO:0030195) | 4.57403476 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.57403476 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.56560042 |
| 49 | glutamate metabolic process (GO:0006536) | 4.55006233 |
| 50 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.52043816 |
| 51 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.52043816 |
| 52 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.50728195 |
| 53 | S-adenosylmethionine metabolic process (GO:0046500) | 4.47325393 |
| 54 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.39557866 |
| 55 | negative regulation of coagulation (GO:0050819) | 4.28282900 |
| 56 | negative regulation of wound healing (GO:0061045) | 4.21838155 |
| 57 | * bile acid and bile salt transport (GO:0015721) | 4.15715353 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.13187786 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.13187786 |
| 60 | flavonoid metabolic process (GO:0009812) | 3.94920507 |
| 61 | alkaloid metabolic process (GO:0009820) | 3.89938058 |
| 62 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.88056974 |
| 63 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.88056974 |
| 64 | daunorubicin metabolic process (GO:0044597) | 3.84236418 |
| 65 | polyketide metabolic process (GO:0030638) | 3.84236418 |
| 66 | doxorubicin metabolic process (GO:0044598) | 3.84236418 |
| 67 | aromatic amino acid family metabolic process (GO:0009072) | 3.81414219 |
| 68 | tryptophan catabolic process (GO:0006569) | 3.81108225 |
| 69 | indole-containing compound catabolic process (GO:0042436) | 3.81108225 |
| 70 | indolalkylamine catabolic process (GO:0046218) | 3.81108225 |
| 71 | triglyceride homeostasis (GO:0070328) | 3.80592377 |
| 72 | acylglycerol homeostasis (GO:0055090) | 3.80592377 |
| 73 | alpha-amino acid catabolic process (GO:1901606) | 3.76023422 |
| 74 | hormone catabolic process (GO:0042447) | 3.74442937 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.69752470 |
| 76 | positive regulation of blood coagulation (GO:0030194) | 3.68827769 |
| 77 | positive regulation of hemostasis (GO:1900048) | 3.68827769 |
| 78 | intestinal cholesterol absorption (GO:0030299) | 3.66550060 |
| 79 | negative regulation of humoral immune response (GO:0002921) | 3.57231210 |
| 80 | response to mercury ion (GO:0046689) | 3.52053633 |
| 81 | regulation of acute inflammatory response (GO:0002673) | 3.49542864 |
| 82 | acute inflammatory response (GO:0002526) | 3.48461534 |
| 83 | positive regulation of coagulation (GO:0050820) | 3.45789670 |
| 84 | cysteine metabolic process (GO:0006534) | 3.42263383 |
| 85 | amino-acid betaine metabolic process (GO:0006577) | 3.42105458 |
| 86 | xenobiotic metabolic process (GO:0006805) | 3.40942854 |
| 87 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.40726699 |
| 88 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.37533904 |
| 89 | primary alcohol catabolic process (GO:0034310) | 3.37213455 |
| 90 | cholesterol efflux (GO:0033344) | 3.33121254 |
| 91 | arginine metabolic process (GO:0006525) | 3.29353022 |
| 92 | tryptophan metabolic process (GO:0006568) | 3.28883001 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.28796363 |
| 94 | primary alcohol metabolic process (GO:0034308) | 3.28088918 |
| 95 | protein-lipid complex remodeling (GO:0034368) | 3.27797841 |
| 96 | macromolecular complex remodeling (GO:0034367) | 3.27797841 |
| 97 | plasma lipoprotein particle remodeling (GO:0034369) | 3.27797841 |
| 98 | cellular amino acid catabolic process (GO:0009063) | 3.19085932 |
| 99 | drug transmembrane transport (GO:0006855) | 3.19061982 |
| 100 | omega-hydroxylase P450 pathway (GO:0097267) | 10.0627152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.65058987 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.95377055 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.90042350 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.92199568 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.77933394 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.77421347 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.47856716 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.12140607 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.84705295 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.60702747 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.60669541 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.48109063 |
| 13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.04718587 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.26104640 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.03587797 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.00069175 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99339290 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97118975 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95405918 |
| 20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.84377278 |
| 21 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.82544870 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.79359337 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.74095251 |
| 24 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.73726988 |
| 25 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.73726988 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.69722522 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.57611999 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56249580 |
| 29 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.53816777 |
| 30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.52548485 |
| 31 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.49265063 |
| 32 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.47905986 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.46774336 |
| 34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.43235649 |
| 35 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43189349 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40850860 |
| 37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39842456 |
| 38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39398251 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33740754 |
| 40 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.26433760 |
| 41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22525132 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19048018 |
| 43 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17632439 |
| 44 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16746923 |
| 45 | ATF3_27146783_Chip-Seq_COLON_Human | 1.15880403 |
| 46 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.12923753 |
| 47 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11025300 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10979269 |
| 49 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08794222 |
| 50 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.07698498 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07453430 |
| 52 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04792376 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.04524387 |
| 54 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03582232 |
| 55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99249877 |
| 56 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98965315 |
| 57 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.96461469 |
| 58 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94120622 |
| 59 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94033629 |
| 60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93119961 |
| 61 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89230707 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87235785 |
| 63 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87176162 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86214038 |
| 65 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83717150 |
| 66 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.82261370 |
| 67 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82138805 |
| 68 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80305644 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79257520 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75598618 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.75281838 |
| 72 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.72996420 |
| 73 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72184570 |
| 74 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.70946865 |
| 75 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.69587477 |
| 76 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.69220730 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69097550 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69097550 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.68854800 |
| 80 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.68347194 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.67995904 |
| 82 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.67693349 |
| 83 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.66487881 |
| 84 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.65653329 |
| 85 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.64853695 |
| 86 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.64585713 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.62923485 |
| 88 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.62268183 |
| 89 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.62002022 |
| 90 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.59837244 |
| 91 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.58724120 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.58517669 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.57601798 |
| 94 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.56015977 |
| 95 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.55348733 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.54995112 |
| 97 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.54681018 |
| 98 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53841536 |
| 99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.53161572 |
| 100 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.53068427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.24387518 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 6.50638867 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.68087729 |
| 4 | MP0005360_urolithiasis | 5.20553618 |
| 5 | MP0005365_abnormal_bile_salt | 4.74786987 |
| 6 | MP0003252_abnormal_bile_duct | 4.21611356 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.77845078 |
| 8 | MP0003195_calcinosis | 3.66748589 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 3.52338175 |
| 10 | MP0009697_abnormal_copulation | 3.00407592 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.81272179 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.44987601 |
| 13 | MP0003868_abnormal_feces_composition | 2.41433535 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.26604157 |
| 15 | MP0005332_abnormal_amino_acid | 2.14776216 |
| 16 | MP0010368_abnormal_lymphatic_system | 1.98146967 |
| 17 | MP0005670_abnormal_white_adipose | 1.90042272 |
| 18 | MP0009840_abnormal_foam_cell | 1.85254872 |
| 19 | MP0000609_abnormal_liver_physiology | 1.82735320 |
| 20 | MP0009053_abnormal_anal_canal | 1.70461975 |
| 21 | MP0001661_extended_life_span | 1.54106189 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.47639916 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.41843112 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.41781724 |
| 25 | MP0002876_abnormal_thyroid_physiology | 1.27146613 |
| 26 | MP0005408_hypopigmentation | 1.25672660 |
| 27 | MP0005023_abnormal_wound_healing | 1.24480626 |
| 28 | MP0001764_abnormal_homeostasis | 1.11330898 |
| 29 | MP0002282_abnormal_trachea_morphology | 1.10715320 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.06052037 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.01300439 |
| 32 | MP0000598_abnormal_liver_morphology | 1.00263563 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98595522 |
| 34 | MP0003566_abnormal_cell_adhesion | 0.95552529 |
| 35 | MP0005083_abnormal_biliary_tract | 0.94777187 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 0.93700718 |
| 37 | MP0009643_abnormal_urine_homeostasis | 0.93406811 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 0.91497661 |
| 39 | MP0009764_decreased_sensitivity_to | 0.90926937 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 0.88148041 |
| 41 | MP0001915_intracranial_hemorrhage | 0.87754555 |
| 42 | MP0005376_homeostasis/metabolism_phenot | 0.87606259 |
| 43 | MP0009763_increased_sensitivity_to | 0.86799294 |
| 44 | MP0005451_abnormal_body_composition | 0.85307490 |
| 45 | MP0002332_abnormal_exercise_endurance | 0.84716601 |
| 46 | MP0003186_abnormal_redox_activity | 0.82798565 |
| 47 | MP0002132_abnormal_respiratory_system | 0.82003395 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 0.79331300 |
| 49 | MP0004272_abnormal_basement_membrane | 0.79229388 |
| 50 | MP0005266_abnormal_metabolism | 0.76521785 |
| 51 | MP0003453_abnormal_keratinocyte_physiol | 0.75728268 |
| 52 | MP0002971_abnormal_brown_adipose | 0.75500052 |
| 53 | MP0005395_other_phenotype | 0.75005554 |
| 54 | MP0000467_abnormal_esophagus_morphology | 0.70011161 |
| 55 | MP0009642_abnormal_blood_homeostasis | 0.69311697 |
| 56 | MP0008469_abnormal_protein_level | 0.68957735 |
| 57 | MP0000537_abnormal_urethra_morphology | 0.67540421 |
| 58 | MP0000858_altered_metastatic_potential | 0.67459932 |
| 59 | MP0008872_abnormal_physiological_respon | 0.65400338 |
| 60 | MP0005164_abnormal_response_to | 0.63555601 |
| 61 | MP0005166_decreased_susceptibility_to | 0.61986338 |
| 62 | MP0005666_abnormal_adipose_tissue | 0.61180597 |
| 63 | MP0005464_abnormal_platelet_physiology | 0.59538926 |
| 64 | MP0005187_abnormal_penis_morphology | 0.58667017 |
| 65 | MP0008874_decreased_physiological_sensi | 0.55856749 |
| 66 | MP0002060_abnormal_skin_morphology | 0.55526311 |
| 67 | MP0000762_abnormal_tongue_morphology | 0.54731455 |
| 68 | MP0005197_abnormal_uvea_morphology | 0.54516089 |
| 69 | MP0001881_abnormal_mammary_gland | 0.52746371 |
| 70 | MP0003718_maternal_effect | 0.52425184 |
| 71 | MP0005257_abnormal_intraocular_pressure | 0.51392791 |
| 72 | MP0002796_impaired_skin_barrier | 0.50386810 |
| 73 | MP0002234_abnormal_pharynx_morphology | 0.50174636 |
| 74 | MP0002168_other_aberrant_phenotype | 0.49848625 |
| 75 | MP0010678_abnormal_skin_adnexa | 0.49497577 |
| 76 | MP0005165_increased_susceptibility_to | 0.48920246 |
| 77 | MP0005334_abnormal_fat_pad | 0.48773245 |
| 78 | MP0003950_abnormal_plasma_membrane | 0.48672425 |
| 79 | MP0000249_abnormal_blood_vessel | 0.48440711 |
| 80 | MP0005501_abnormal_skin_physiology | 0.47212314 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.45146860 |
| 82 | MP0001851_eye_inflammation | 0.44952272 |
| 83 | MP0004185_abnormal_adipocyte_glucose | 0.44837873 |
| 84 | MP0000627_abnormal_mammary_gland | 0.44740665 |
| 85 | MP0003638_abnormal_response/metabolism_ | 0.44403301 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.43782494 |
| 87 | MP0003075_altered_response_to | 0.42531688 |
| 88 | MP0000604_amyloidosis | 0.40817959 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.39910540 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.39694190 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.37380710 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.37072373 |
| 93 | MP0005535_abnormal_body_temperature | 0.36748600 |
| 94 | MP0008873_increased_physiological_sensi | 0.36378513 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 0.34083067 |
| 96 | MP0002697_abnormal_eye_size | 0.33956420 |
| 97 | MP0002249_abnormal_larynx_morphology | 0.33649034 |
| 98 | MP0006036_abnormal_mitochondrial_physio | 0.33353058 |
| 99 | MP0002970_abnormal_white_adipose | 0.32979414 |
| 100 | MP0009785_altered_susceptibility_to | 0.31877098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.66783207 |
| 2 | Deep venous thrombosis (HP:0002625) | 9.08698010 |
| 3 | Abnormality of complement system (HP:0005339) | 8.67955823 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.67111833 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 8.47321995 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.99664918 |
| 7 | * Conjugated hyperbilirubinemia (HP:0002908) | 6.43417804 |
| 8 | Joint hemorrhage (HP:0005261) | 6.29180300 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 5.75039774 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 5.37816922 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 5.10454143 |
| 12 | Abnormality of the intrinsic pathway (HP:0010989) | 5.08822060 |
| 13 | Glomerulonephritis (HP:0000099) | 4.84964807 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.83502285 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.77874547 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.54230907 |
| 17 | Xanthomatosis (HP:0000991) | 4.46378341 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.34320817 |
| 19 | Spontaneous abortion (HP:0005268) | 4.30447108 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 3.90622081 |
| 21 | Nephritis (HP:0000123) | 3.90270883 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.71709952 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.70178184 |
| 24 | Hepatocellular carcinoma (HP:0001402) | 3.48802757 |
| 25 | Delayed CNS myelination (HP:0002188) | 3.18294209 |
| 26 | Fair hair (HP:0002286) | 3.05244561 |
| 27 | Fat malabsorption (HP:0002630) | 2.94577393 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.92484541 |
| 29 | Vascular calcification (HP:0004934) | 2.91711438 |
| 30 | Hypercholesterolemia (HP:0003124) | 2.85291427 |
| 31 | Neonatal hypoglycemia (HP:0001998) | 2.84475907 |
| 32 | Hyperammonemia (HP:0001987) | 2.80499301 |
| 33 | Abnormality of nucleobase metabolism (HP:0010932) | 2.73030742 |
| 34 | Mitral stenosis (HP:0001718) | 2.69714704 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.68486540 |
| 36 | Cardiovascular calcification (HP:0011915) | 2.54194632 |
| 37 | Gingival bleeding (HP:0000225) | 2.51441722 |
| 38 | Epidermoid cyst (HP:0200040) | 2.49453598 |
| 39 | Hemorrhage of the eye (HP:0011885) | 2.44339246 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.40153310 |
| 41 | Generalized aminoaciduria (HP:0002909) | 2.33240551 |
| 42 | Hyperglycinemia (HP:0002154) | 2.31898618 |
| 43 | Menorrhagia (HP:0000132) | 2.28329323 |
| 44 | Reduced antithrombin III activity (HP:0001976) | 2.23747198 |
| 45 | * Hyperbilirubinemia (HP:0002904) | 2.23428234 |
| 46 | Generalized hypopigmentation of hair (HP:0011358) | 2.22103949 |
| 47 | Osteomalacia (HP:0002749) | 2.17961108 |
| 48 | Rickets (HP:0002748) | 2.17430447 |
| 49 | Steatorrhea (HP:0002570) | 2.14010825 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 2.10787529 |
| 51 | Cholelithiasis (HP:0001081) | 2.08280128 |
| 52 | Thrombophlebitis (HP:0004418) | 2.06811318 |
| 53 | Gout (HP:0001997) | 2.06667649 |
| 54 | Amyloidosis (HP:0011034) | 2.03952771 |
| 55 | Skin nodule (HP:0200036) | 2.03662820 |
| 56 | Elevated alkaline phosphatase (HP:0003155) | 2.03367994 |
| 57 | Complement deficiency (HP:0004431) | 10.3417415 |
| 58 | Periodontitis (HP:0000704) | 1.97758710 |
| 59 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.97421167 |
| 60 | Abnormality of glycine metabolism (HP:0010895) | 1.97421167 |
| 61 | Focal segmental glomerulosclerosis (HP:0000097) | 1.91680463 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 1.89957626 |
| 63 | Increased serum ferritin (HP:0003281) | 1.89003658 |
| 64 | Cholecystitis (HP:0001082) | 1.88441068 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 1.88441068 |
| 66 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87891338 |
| 67 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.86929319 |
| 68 | Abnormality of the Achilles tendon (HP:0005109) | 1.83712161 |
| 69 | Increased mean platelet volume (HP:0011877) | 1.82678771 |
| 70 | Purpura (HP:0000979) | 1.82643204 |
| 71 | Metabolic acidosis (HP:0001942) | 1.81369674 |
| 72 | Glomerulosclerosis (HP:0000096) | 1.81026735 |
| 73 | Increased serum pyruvate (HP:0003542) | 1.79618999 |
| 74 | Abnormality of purine metabolism (HP:0004352) | 1.79143998 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 1.78054646 |
| 76 | Abnormal delivery (HP:0001787) | 1.76386702 |
| 77 | Myocardial infarction (HP:0001658) | 1.71343443 |
| 78 | Abnormal platelet function (HP:0011869) | 1.69751804 |
| 79 | Impaired platelet aggregation (HP:0003540) | 1.69751804 |
| 80 | Cerebral palsy (HP:0100021) | 1.69074504 |
| 81 | Joint swelling (HP:0001386) | 1.64627189 |
| 82 | Abnormality of glycolysis (HP:0004366) | 1.63441873 |
| 83 | Blue irides (HP:0000635) | 1.63346054 |
| 84 | Arthropathy (HP:0003040) | 1.60377125 |
| 85 | Hyperphosphaturia (HP:0003109) | 1.54363470 |
| 86 | Abnormal platelet volume (HP:0011876) | 1.54169018 |
| 87 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.53423065 |
| 88 | Ketosis (HP:0001946) | 1.53333647 |
| 89 | Bifid scrotum (HP:0000048) | 1.50537690 |
| 90 | Osteolytic defects of the hand bones (HP:0009699) | 1.48235928 |
| 91 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.48235928 |
| 92 | Abnormality of vitamin metabolism (HP:0100508) | 1.45796820 |
| 93 | Hypophosphatemic rickets (HP:0004912) | 1.45108927 |
| 94 | Atrioventricular block (HP:0001678) | 1.44615784 |
| 95 | Irritability (HP:0000737) | 1.44380590 |
| 96 | Back pain (HP:0003418) | 1.43731707 |
| 97 | Epistaxis (HP:0000421) | 1.37797572 |
| 98 | Pulmonary embolism (HP:0002204) | 1.35761738 |
| 99 | Abnormal tarsal ossification (HP:0008369) | 1.35078941 |
| 100 | Hyperglycemia (HP:0003074) | 1.34064725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 9.69338962 |
| 2 | EPHA2 | 6.13315932 |
| 3 | MET | 4.68380652 |
| 4 | ERN1 | 2.45573101 |
| 5 | IRAK3 | 2.26584870 |
| 6 | NME2 | 2.11905335 |
| 7 | LMTK2 | 2.04309730 |
| 8 | SIK1 | 1.98661923 |
| 9 | MST4 | 1.89081927 |
| 10 | SCYL2 | 1.85795589 |
| 11 | MAP3K12 | 1.84906658 |
| 12 | EIF2AK1 | 1.76030633 |
| 13 | ERBB4 | 1.63488655 |
| 14 | PBK | 1.59908774 |
| 15 | EPHB2 | 1.59273221 |
| 16 | PAK4 | 1.44827030 |
| 17 | PTK2 | 1.34204137 |
| 18 | ARAF | 1.32892660 |
| 19 | ERBB3 | 1.28377108 |
| 20 | MAP3K9 | 1.24076217 |
| 21 | STK10 | 1.22784676 |
| 22 | BRSK2 | 1.16231328 |
| 23 | MOS | 1.11680801 |
| 24 | EPHB1 | 1.11492596 |
| 25 | TESK1 | 1.08206818 |
| 26 | BMX | 1.06796439 |
| 27 | LATS1 | 1.03173726 |
| 28 | FGFR4 | 1.02395260 |
| 29 | TRIB3 | 0.99376063 |
| 30 | BUB1 | 0.98014354 |
| 31 | BRSK1 | 0.94164969 |
| 32 | TGFBR2 | 0.93863218 |
| 33 | NEK1 | 0.91257316 |
| 34 | LATS2 | 0.90147492 |
| 35 | ABL2 | 0.86653166 |
| 36 | LIMK1 | 0.84324149 |
| 37 | NEK9 | 0.80196908 |
| 38 | PRPF4B | 0.77699883 |
| 39 | CDK8 | 0.71082597 |
| 40 | EIF2AK3 | 0.70843078 |
| 41 | MAP3K3 | 0.69331894 |
| 42 | PDGFRA | 0.68308546 |
| 43 | STK38L | 0.67682012 |
| 44 | MAP3K13 | 0.66691566 |
| 45 | MELK | 0.66047013 |
| 46 | MAP3K2 | 0.65539457 |
| 47 | FER | 0.64751515 |
| 48 | TRPM7 | 0.64307735 |
| 49 | RIPK1 | 0.63823917 |
| 50 | EIF2AK2 | 0.62588329 |
| 51 | ICK | 0.62011494 |
| 52 | TTN | 0.61899484 |
| 53 | IGF1R | 0.60683843 |
| 54 | STK39 | 0.59925687 |
| 55 | PIK3CG | 0.57800427 |
| 56 | MAPK11 | 0.57393082 |
| 57 | MYLK | 0.56727728 |
| 58 | DAPK1 | 0.55821240 |
| 59 | PRKCI | 0.52873483 |
| 60 | KSR1 | 0.48171015 |
| 61 | SIK3 | 0.46441116 |
| 62 | BMPR2 | 0.45384915 |
| 63 | NTRK1 | 0.45225071 |
| 64 | TAOK2 | 0.44085695 |
| 65 | CAMK2G | 0.43137750 |
| 66 | BCR | 0.42710956 |
| 67 | CSF1R | 0.41836672 |
| 68 | TESK2 | 0.41526700 |
| 69 | PTK6 | 0.41001684 |
| 70 | PIK3CA | 0.39521995 |
| 71 | AURKB | 0.38531033 |
| 72 | JAK1 | 0.38236044 |
| 73 | PHKG2 | 0.37782887 |
| 74 | PHKG1 | 0.37782887 |
| 75 | PRKACG | 0.37478448 |
| 76 | STK38 | 0.36785192 |
| 77 | ILK | 0.36425345 |
| 78 | PRKAA2 | 0.36114510 |
| 79 | MAP3K8 | 0.35111816 |
| 80 | BRAF | 0.34347974 |
| 81 | NEK2 | 0.32198001 |
| 82 | MTOR | 0.31595883 |
| 83 | CDK6 | 0.30807171 |
| 84 | SRPK1 | 0.29696677 |
| 85 | PDGFRB | 0.29177398 |
| 86 | AURKA | 0.28379341 |
| 87 | LRRK2 | 0.27524312 |
| 88 | CDK9 | 0.26585623 |
| 89 | MAP3K6 | 0.26287173 |
| 90 | AKT2 | 0.24314740 |
| 91 | TTK | 0.24239907 |
| 92 | GSK3A | 0.22802640 |
| 93 | CAMK2D | 0.21717703 |
| 94 | WEE1 | 0.21419505 |
| 95 | TYK2 | 0.20834576 |
| 96 | ADRBK1 | 0.20425117 |
| 97 | PDK2 | 0.20346691 |
| 98 | CAMK2B | 0.20241677 |
| 99 | CAMKK2 | 0.20078665 |
| 100 | RPS6KA4 | 0.19501167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.91343236 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.75028153 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.02417738 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.58523638 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.44267535 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.42025626 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.12215566 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.82075068 |
| 9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.79927744 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.74813332 |
| 11 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.58641166 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53016872 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51142663 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.48143456 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46612723 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44004713 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.41269608 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.02793012 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97381104 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.67262956 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.67122009 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.66864693 |
| 23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.64257438 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.63471450 |
| 25 | Prion diseases_Homo sapiens_hsa05020 | 1.52466194 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48955797 |
| 27 | * Bile secretion_Homo sapiens_hsa04976 | 1.47275294 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.46693503 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.46261847 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.44586661 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.35454518 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31193497 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.23291164 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21628824 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19945164 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.15845794 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15000796 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13735781 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10447979 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03102718 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98709802 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 0.98037026 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97554607 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94168871 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90814983 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88479331 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.71042909 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.69745964 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.68166900 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.66110557 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66003174 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51876188 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48658436 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45515490 |
| 55 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44451211 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43390382 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40090763 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37117283 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.32616343 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30387622 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29898225 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.29312959 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.25476345 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25050010 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23301626 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23222757 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.22867788 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20694924 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.14857883 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.13350138 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.13083145 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.12652944 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08888239 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06552521 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.06165433 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.03484807 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01731464 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.00409533 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | -0.1993423 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | -0.1845426 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1674369 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1524068 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.1404402 |
| 84 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1381536 |
| 85 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1235325 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1234284 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | -0.1119980 |
| 88 | Proteasome_Homo sapiens_hsa03050 | -0.0920633 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0665895 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0643613 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0642846 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0554357 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0315210 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0272043 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0230954 |
| 96 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0174025 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0132015 |
| 98 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0117416 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0103642 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0054725 |

